SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-016643
Filing Date
2021-05-10
Accepted
2021-05-10 16:46:52
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10024322_10q.htm   iXBRL 10-Q 1158683
2 EXHIBIT 31.1 brhc10024322_ex31-1.htm EX-31.1 12625
3 EXHIBIT 31.2 brhc10024322_ex31-2.htm EX-31.2 13194
4 EXHIBIT 32.1 brhc10024322_ex32-1.htm EX-32.1 6935
10 image0.jpg GRAPHIC 22803
11 image1.jpg GRAPHIC 22014
  Complete submission text file 0001140361-21-016643.txt   6579219

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20210331.xsd EX-101.SCH 48434
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20210331_cal.xml EX-101.CAL 64337
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20210331_def.xml EX-101.DEF 255134
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20210331_lab.xml EX-101.LAB 733865
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20210331_pre.xml EX-101.PRE 410684
12 EXTRACTED XBRL INSTANCE DOCUMENT brhc10024322_10q_htm.xml XML 1010047
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 21907970
SIC: 2834 Pharmaceutical Preparations